P53-R172H cooperates with Brd4 to induce Csf-1 expression and lung metastasis: H3K27ac profile of mouse ESCC cells with Trp53R172/- or Trp53+/+
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA973700 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR24624581_1.fastq.gz | Fastqsanger.gz | |||
| SRR24624581_2.fastq.gz | Fastqsanger.gz | |||
| SRR24624582_1.fastq.gz | Fastqsanger.gz | |||
| SRR24624582_2.fastq.gz | Fastqsanger.gz | |||
| SRR24624583_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 28 |
Similar Datasets
Project description:TP53 mutations are frequent in esophageal squamous cell carcinoma (ESCC), and other SCCs, and are associated with a proclivity for metastasis. Here, we report that the Colony-Stimulating Factor-1 (CSF-1) expression is upregulated significantly in a p53-R175H (R172H in mice)-mediated manner in lung metastatic lesions of ESCC. The p53-R172H-dependent Csf-1 signaling through its cognate receptor Csf-1r increases tumor cell invasion and lung metastasis, which is mediated in part through the phosphorylation of Stat3 and epithelial-to-mesenchymal transition. In Trp53R172H tumor cells, p53 binds to the Csf-1 promoter and the Csf-1 locus is enriched with H3K27ac, which likely is permissive for fostering an interaction between Brd4 and p53-R172H to regulate the Csf-1 transcription. Inhibition of Brd4 not only reduces tumor invasion and lung metastasis but also reduces the Csf-1 level in circulation. Overall, our results establish that the p53-R175H-mediated Brd4-Csf-1 axis promotes ESCC lung metastasis and suggest avenues for therapeutic strategies for this difficult to treat disease. To elucidate the mechanism for how Trp53R172H regulates Csf-1 transcription, we conducted Cleavage Under Targets and Release Using Nuclease sequencing (CUT&RUN-seq) for histone 3 lysine 27 acetylation (H3K27ac), which is an active enhancer and promoter marker [48], on Trp53R172H/- or Trp53+/+ ESCC cells. The genome-wide analysis revealed 1189 genes having enriched and 1454 genes having depleted H3K27ac in Trp53R172H/- tumor cells compared to Trp53+/+ cells (|log2fold change| > 1.5). Notably, H3K27ac peaks were enriched across Vim gene encoding the mesenchymal marker Vimentin and were reduced across Cdh1 gene encoding the epithelial marker E- Cadherin in Trp53R172H tumor cells compared to Trp53+/+ cells. Interestingly, H3K27ac peaks were enriched across Csf-1 locus including the promoter site in Trp53R172H/- ESCC cells compared to Trp53+/+ tumor cells, suggesting that the Csf-1 locus was accessible and active in the presence of p53-R172H. The epigenetic reader Brd4 binds to acetylated histone lysine residues at promoters and super-enhancers to regulate transcription initiation [29]. We therefore investigated if Brd4 was recruited to enriched H3K27ac sites in ESCC cells to upregulate Csf-1. We found that global Brd4 level in Trp53R172H/- tumor cells was ~2-fold higher than in Trp53-/- cells and ~3-fold higher than in Trp53+/+ cells suggesting gain-of-function properties of p53-R172.
2024-05-31 | GSE232757 | GEO
Project description:Periostin, a matricellular protein, has been reported to be important in supporting tumor cell dissemination. However, the molecular mechanisms underlying periostin function within the tumor microenvironment are poorly understood. In this study, we observe that loss of periostin decreases esophageal squamous cell carcinoma (ESCC) tumor growth in vivo and demonstrate that periostin cooperates with a conformational missense p53 mutation to enhance invasion. Pathway analyses reveal that invasive esophageal cells expressing periostin and p53R175H mutation display activation of signal transducer and activator of transcription 1 (STAT1) target genes, suggesting that the induction of STAT1 and STAT1-related genes could foster a permissive microenvironment that facilitates invasion of esophageal epithelial cells into the extracellular matrix (ECM). Genetic knockdown of STAT1 in transformed esophageal epithelial cells underscores the importance of STAT1 in promoting invasion and potentiate tumor resistance to genotoxic stress. Furthermore, we find that STAT1 is activated in ESCC xenograft tumors but this activation is attenuated with inducible knockdown of periostin in ESCC tumors. Overall, these results highlight the molecular mechanisms supporting the capacity of periostin in mediating tumor invasion during ESCC development. Pre-clinical study hTERT: EPC cells immortalized by expression of hTERT hTERT_p53: EPC cells expressing hTERT and mutant P53 hTERT_p53_POSTN: EPC cells expressing hTERT, mutant P53, and POSTN.
2016-06-01 | E-GEOD-48999 | biostudies-arrayexpress
Project description:To understand the difference of protein expression between paired esophageal squamous cell carcinoma (ESCC) and adjacent normal tissues, we collected 10 paired ESCC and normal tissues from surgical resected specimems for high-throughput proteomic experiments. From comparative analysis, the dysregulated signaling pathways in ESCC could be uncovered.
2020-08-11 | PXD019834 | Pride
Project description:To discover ESCC related proteins, we used SWATH to quantify the protein abundance between ESCC and adjacent tissues. Briefly, we pooled 10 ESCCtissues and their corresponding adjacent tissues for SWATH acquisition with three replicates.Three DDA repeats were also acquired with the pooled 10-paired ESCC tissue.The trypsin digested peptide mixture was analyzed by AB SCIEX 5600 (AB SCIEX).The database searching procedure was achieved using ProteinPilot v4.5 (AB Sciex). The database is IPI_homo_sapiens_V3.87.
2015-09-22 | PXD001764 | Pride
Project description:Myc expression cooperates with Rb1 and Trp53 loss in mouse lungs to generate rapid, aggressive, highly metastatic and neuroendocrine-low tumors that are similar to human variant subset of SCLC with high NEUROD1 expression. Targeted drug screening reveals that mouse and human MYC-driven SCLC are vulnerable to Aurora kinase inhibition in combination with chemotherapy in vivo.
2017-01-12 | GSE89660 | GEO
Project description:NRF2 activation in TRP53:P16 deficient mice drives oral squamous cell carcinoma
2024-01-31 | PXD048887 | Pride
Project description:Periostin, a matricellular protein, has been reported to be important in supporting tumor cell dissemination. However, the molecular mechanisms underlying periostin function within the tumor microenvironment are poorly understood. In this study, we observe that loss of periostin decreases esophageal squamous cell carcinoma (ESCC) tumor growth in vivo and demonstrate that periostin cooperates with a conformational missense p53 mutation to enhance invasion. Pathway analyses reveal that invasive esophageal cells expressing periostin and p53R175H mutation display activation of signal transducer and activator of transcription 1 (STAT1) target genes, suggesting that the induction of STAT1 and STAT1-related genes could foster a permissive microenvironment that facilitates invasion of esophageal epithelial cells into the extracellular matrix (ECM). Genetic knockdown of STAT1 in transformed esophageal epithelial cells underscores the importance of STAT1 in promoting invasion and potentiate tumor resistance to genotoxic stress. Furthermore, we find that STAT1 is activated in ESCC xenograft tumors but this activation is attenuated with inducible knockdown of periostin in ESCC tumors. Overall, these results highlight the molecular mechanisms supporting the capacity of periostin in mediating tumor invasion during ESCC development.
2016-06-01 | GSE48999 | GEO
Project description:We detected DNA methylation of 15 ESCC samples' tumor tissues and their pericarcinomatous tissues to identify the aberrant DNA methylation status in ESCC.
2021-10-28 | GSE121930 | GEO
Project description:We analyzed miRNA-based shRNA off-target effects by transducing Trp53-/- MEFs at single- and high-copy with six well-characterized, potent and weak Trp53 shRNAs. To advance RNAi therapy for KRAS-mutant cancer, we developed a functionally validated library of siRNAs against RAS pathway genes that minimize off-target effects and enable combination gene silencing at low dose. We developed an in vivo model for real-time tracking of nanoparticle-based siRNA delivery and offer proof-of-principle that siRNA-mediated inhibition of a single gene (KRAS) or combinations of genes (A/B/C-RAF or KRAS+PIK3C-A/B) can impair the growth of KRAS-mutant colorectal cancer xenografts. Trp53-/- MEFs were transduced with LMP expressing Trp53 shRNAs at single copy (11-21% infection efficiency) and high copy (>98% infection efficiency), selected on puromycin and grown in absence of the selection agent before harvest. Uninfected Trp53-/- MEFs and Trp53-/- MEFs infected with an empty vector control served as M-bM-^@M-^\no shRNAM-bM-^@M-^] reference.
2014-08-01 | E-GEOD-59952 | biostudies-arrayexpress